These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 21878041

  • 1. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R, Ceconi C.
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
    [Abstract] [Full Text] [Related]

  • 2. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 3. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C.
    Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003
    [Abstract] [Full Text] [Related]

  • 4. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
    Reil JC, Reil GH, Böhm M.
    Trends Cardiovasc Med; 2009 Jul 06; 19(5):152-7. PubMed ID: 20005474
    [Abstract] [Full Text] [Related]

  • 5. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N.
    Therapie; 2009 Jul 06; 64(2):111-4. PubMed ID: 19664404
    [Abstract] [Full Text] [Related]

  • 6. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Jul 06; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Jul 06; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 10. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 11. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E, Lerebours G, Vilaine JP.
    Ann N Y Acad Sci; 2011 Mar 27; 1222():90-9. PubMed ID: 21434947
    [Abstract] [Full Text] [Related]

  • 12. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E, Bonadei I, D'Aloia A, Del Magro F, Piovanelli B, Bontempi L, Curnis A, Dei Cas L.
    Minerva Med; 2011 Oct 27; 102(5):373-9. PubMed ID: 22193347
    [Abstract] [Full Text] [Related]

  • 13. I(f) inhibition in cardiovascular diseases.
    Thollon C, Vilaine JP.
    Adv Pharmacol; 2010 Oct 27; 59():53-92. PubMed ID: 20933199
    [Abstract] [Full Text] [Related]

  • 14. Anti-ischaemic effect of ivabradine.
    Ferrari R, Cargnoni A, Ceconi C.
    Pharmacol Res; 2006 May 27; 53(5):435-9. PubMed ID: 16644235
    [Abstract] [Full Text] [Related]

  • 15. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J, Varela A.
    Am J Cardiovasc Drugs; 2009 May 27; 9 Suppl 1():9-12. PubMed ID: 20000882
    [Abstract] [Full Text] [Related]

  • 16. Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.
    Monnet X, Ghaleh B, Colin P, de Curzon OP, Giudicelli JF, Berdeaux A.
    J Pharmacol Exp Ther; 2001 Dec 27; 299(3):1133-9. PubMed ID: 11714904
    [Abstract] [Full Text] [Related]

  • 17. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
    Dedkov EI, Bogatyryov Y, McCooey DS, Christensen LP, Weiss RM, Tomanek RJ.
    J Cardiovasc Pharmacol Ther; 2015 May 27; 20(3):299-312. PubMed ID: 25287895
    [Abstract] [Full Text] [Related]

  • 18. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
    Su JB.
    Curr Pharm Biotechnol; 2014 May 27; 14(14):1213-9. PubMed ID: 24831809
    [Abstract] [Full Text] [Related]

  • 19. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs.
    Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A.
    J Pharmacol Exp Ther; 2004 Jan 27; 308(1):236-40. PubMed ID: 14569053
    [Abstract] [Full Text] [Related]

  • 20. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
    Rosano GM, Vitale C, Volterrani M.
    Adv Ther; 2010 Apr 27; 27(4):202-10. PubMed ID: 20495895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.